Transmission of Carbapenemase Genes in CREC: Insights from G
2026-04-19
Transmission Dynamics of Carbapenemase-Encoding Genes in CREC: A Multi-Hospital Study from Guangdong
Study Background and Research Question
Carbapenem-resistant Enterobacter cloacae (CREC) has emerged as a major public health concern, particularly in the context of the COVID-19 pandemic, which exacerbated antimicrobial resistance due to increased antibiotic usage and healthcare disruptions. While CREC ranks third among carbapenem-resistant Enterobacteriaceae in China, detailed molecular epidemiology and transmission analyses have been limited. The central research question of Chen et al. (2025) was to determine the molecular characteristics, prevalence, and transmission patterns of carbapenemase-encoding genes (CEGs) within CREC isolates from eight tertiary teaching hospitals in Guangdong province (paper).Key Innovation from the Reference Study
Unlike prior studies that focused on single hospitals or provided limited genetic context, this study offers a comprehensive, multicenter snapshot of CREC in a densely populated region during a period of heightened antimicrobial pressure. The authors used a combination of plasmid elimination, PCR, conjugation assays, and genotyping to systematically map the distribution, genetic localization (chromosomal vs. plasmid), and transferability of key CEGs. Most notably, the work quantifies the dominance of the blaNDM-1 gene on plasmids and documents the high efficiency of horizontal gene transfer for these resistance elements (paper).Methods and Experimental Design Insights
The study analyzed 54 non-duplicate CREC isolates collected between December 2022 and June 2024 from diverse clinical departments. Key methodologies included:- Variable temperature SDS plasmid elimination: Used to distinguish chromosomal from plasmid-borne resistance genes.
- PCR amplification: Targeted detection of blaNDM-1, blaIMP, and blaKPC-2 genes to establish prevalence and co-occurrence.
- Broth microdilution: Quantified antibiotic susceptibility, including to fluoroquinolone antibiotics such as ciprofloxacin and levofloxacin.
- Plasmid conjugation experiments: Assessed horizontal transfer rates of resistance genes.
- ERIC-PCR and NTSYS clustering: Genotyped isolates to map clonal dissemination and diversity.
Protocol Parameters
- assay | Broth microdilution | value_with_unit | MIC ranges for ciprofloxacin (mg/L) | applicability | CREC susceptibility profiling | rationale | Standardized assessment of fluoroquinolone resistance | source_type | paper
- assay | PCR detection | value_with_unit | Primer sets for blaNDM-1, blaIMP, blaKPC-2 | applicability | Identification of CEGs | rationale | High sensitivity for resistance gene detection | source_type | paper
- assay | Plasmid conjugation | value_with_unit | 95.65% transfer success | applicability | Horizontal gene transfer analysis | rationale | Quantifies mobility of CEGs | source_type | paper
- assay | Chromosomal vs. plasmid mapping | value_with_unit | Variable temperature SDS method | applicability | Genetic localization of CEGs | rationale | Differentiates chromosomal from plasmid-borne genes | source_type | paper
- assay | Workflow recommendation | value_with_unit | Use high-purity fluoroquinolone antibiotic for reproducible results | applicability | Antimicrobial resistance research | rationale | Ensures reliability in susceptibility and mechanism studies | source_type | workflow_recommendation
Core Findings and Why They Matter
Among the 54 CREC isolates, 85.19% carried at least one carbapenemase-encoding gene, with blaNDM-1 detected in 79.63% (predominantly plasmid-borne). The high prevalence of plasmid-localized blaNDM-1 is significant, as it implies a greater risk for horizontal gene transfer and broader dissemination of resistance (paper). Conjugation assays demonstrated a transfer success rate of 95.65% for CEGs, underscoring the efficiency of horizontal gene transfer mechanisms in clinical environments. Resistance profiling revealed that CEG-positive isolates exhibited significantly higher resistance rates to multiple antibiotics, including ciprofloxacin and levofloxacin, compared to CEG-negative strains (P < 0.05) (paper). This finding highlights the urgent need to monitor fluoroquinolone antibiotic susceptibility as part of comprehensive antimicrobial resistance research. Six distinct mobile genetic elements (MGEs) were identified, with ISEcp1 present in 87.04% of isolates. The presence of multiple MGEs in single strains (up to four types in some cases) further enhances the potential for rapid resistance spread. Clonal analysis grouped isolates into 17 genotypes, with two (type E and type G) showing the highest prevalence and distribution across multiple hospitals, indicating both clonal expansion and inter-institutional transmission. Epidemiologically, higher CEG detection rates were observed in males, the elderly, respiratory medicine departments, and sputum samples.Comparison with Existing Internal Articles
The present study’s findings align with themes explored in existing technical guides:- The article "Ciprofloxacin: Fluoroquinolone Antibiotic for Antimicrobial Resistance Research" emphasizes the utility of ciprofloxacin for dissecting resistance mechanisms and DNA replication inhibition. Chen et al.'s demonstration of high-level fluoroquinolone resistance in CREC reinforces the importance of standardized, research-grade fluoroquinolone use in susceptibility testing and resistance modeling.
- "Reframing Antimicrobial Resistance Research: Mechanistic Perspectives" contextualizes the dynamic, multi-gene transmission observed in the Guangdong study, highlighting the relevance of detailed molecular epidemiology for experimental design and translational research in resistance gene propagation.
- Workflow guides such as "Ciprofloxacin for Resistance Studies" advocate for the use of high-purity fluoroquinolone antibiotics to ensure reproducibility in both phenotypic and mechanistic studies, a principle supported by the multidrug resistance patterns documented in the CREC isolates.